Hunger, Robert E; Kernland Lang, Kristin; Markowski, Carrie J; Trachsel, Sissel; Møller, Mona; Eriksen, Jon A; Rasmussen, Anne-Marie; Braathen, Lasse R; Gaudernack, Gustav (2011). Vaccination of patients with cutaneous melanoma with telomerase-specific peptides. Cancer immunology, immunotherapy, 60(11), pp. 1553-64. Heidelberg: Springer-Verlag 10.1007/s00262-011-1061-z
|
Text
262_2011_Article_1061.pdf - Published Version Available under License Publisher holds Copyright. Download (2MB) | Preview |
A phase I study was conducted to investigate the safety, tolerability, and immunological responses to vaccination with a combination of telomerase-derived peptides GV1001 (hTERT: 611-626) and p540 (hTERT: 540-548) using granulocyte-macrophage colony-stimulating factor (GM-CSF) or tuberculin as adjuvant in patients with cutaneous melanoma.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Hunger, Robert |
ISSN: |
0340-7004 |
Publisher: |
Springer-Verlag |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:21 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1007/s00262-011-1061-z |
PubMed ID: |
21681371 |
Web of Science ID: |
000296084700004 |
BORIS DOI: |
10.7892/boris.7070 |
URI: |
https://boris.unibe.ch/id/eprint/7070 (FactScience: 212220) |
Actions (login required)
 |
Edit item |